PROVIDENCE CEDARS-SINAI TARZANA MEDI — History
CCN 050761 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$293M
Latest Revenue (FY2022)
+2.5%
Revenue CAGR (3yr)
-33.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $279M | $292M | $293M | +0.3% | +2.5% |
| Operating Expenses | $366M | $361M | $392M | +8.5% | +3.5% |
| Operating Margin | -31.2% | -23.6% | -33.8% | -43.0% | +0.0% |
| Net Income | $-87M | $-69M | $-99M | -43.4% | +0.0% |
| Licensed Beds | 249 | 227 | 218 | -4.0% | -6.4% |
| Total Patient Days | 46,482 | 49,808 | 49,090 | -1.4% | +2.8% |
| Medicare Day % | 33% | 30% | 31% | +3.2% | -2.3% |
| Medicaid Day % | nan% | nan% | 22% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +5.0% ($279M → $293M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.5%
This Hospital
+7.6%
State Avg
Latest Margin
-33.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $300M | -35.1% |
| FY2024 (proj) | $307M | -36.4% |
| FY2025 (proj) | $314M | -37.7% |